Brief: AstraZeneca Says To Acquire Icosavax for $1.1 bln

Icosavax

12/12/2023 07:12

Dec 12 (Reuters) - AstraZeneca PLC  AZN.L :
    * ASTRAZENECA TO ACQUIRE ICOSAVAX
    * ASTRAZENECA TO ACQUIRE ICOSAVAX, INCLUDING POTENTIAL
FIRST-IN-CLASS RSV AND HMPV COMBINATION VACCINE WITH POSITIVE
PHASE II DATA
    * PROPOSED DEAL FOR $15.00 PER SHARE IN CASH AT CLOSING
    * UPFRONT CASH PORTION OF CONSIDERATION REPRESENTS A
TRANSACTION
VALUE OF APPROXIMATELY $0.8BN
    * COMBINED, UPFRONT AND MAXIMUM POTENTIAL CONTINGENT VALUE
PAYMENTS REPRESENT, IF ACHIEVED, A TRANSACTION VALUE OF ABOUT
$1.1BN

Source text for Eikon:  ID:nRSL4665Wa 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;;))